The Alternative Mechanism (Group of Ministers) approved the highest bid of Rs. 121,00,94,400 (One Hundred Twenty One Crores Ninety Four Thousand Four Hundred) from M/s. Skymap Pharmaceuticals Private Limited
The approval covers sale of 100% equity shareholding of Indian Medicines Pharmaceutical Corporation Limited (IMPCL) along with transfer of management control
IMPCL was incorporated on July 12, 1978 with prime objective of manufacturing and supplying standardised Ayurvedic and Unani Medicines
Cabinet Committee on Economic Affairs (CCEA) granted 'in-principle' approval in November 2017 for strategic disinvestment of entire equity shareholding
The disinvestment process used a two-stage competitive bidding process
Preliminary Information Memorandum was issued on 01.09.2023 inviting Expression of Interest
07 Interested Parties expressed interest, all were shortlisted as qualified bidders
Request for Proposal along with Share Purchase Agreement was issued on 01.12.2025
Two sealed financial bids were received by due date 20.01.2026
Both bids were evaluated and found technically qualified
The winning bid of Rs. 121,00,94,400 was above the reserve price
The transaction involved multi-layered consultative decision-making mechanism including Inter-Ministerial Group, Core Group of Secretaries on Disinvestment, and Alternative Mechanism
Letter of Award has been issued to Successful Bidder
Secretary, DIPAM and Secretary, AYUSH authorized to complete and close the transaction
